...
首页> 外文期刊>Revista Brasileira de Anestesiologia >Formula??es de anestésicos locais de libera??o controlada: aplica??es terapêuticas
【24h】

Formula??es de anestésicos locais de libera??o controlada: aplica??es terapêuticas

机译:控释局部麻醉剂:治疗应用

获取原文
           

摘要

BACKGROUND AND OBJECTIVES: Many researchers in the last four decades have been devoted to the development of drug-delivery systems. Since its first application in the pharmaceutical industry, many results have been obtained especially in the molecular manipulation of carriers and their interaction with encapsulated drugs. These new carriers have the advantage of bypassing encapsulated drugs restraining physicochemical properties (such as water or membrane solubility), thus improving pharmacodynamics (therapeutic effect potentiation), pharmacokinetics (control of tissue absorption and distribution) and toxic effects (lower local and systemic toxicity). Liposomes and cyclodextrins are among the most important carriers which have shown to be quite advantageous in the development of drug-delivery systems for local anesthetics. This study aimed at reviewing the interaction of local anesthetics with liposomes and cyclodextrins, the development of basic and applied research on the field, in addition to therapeutic applicability of these formulations. CONTENTS: Liposomes have the ability to control drug delivery to target tissues, fractionating drug release in its site of action. Cyclodextrins, on the other hand, change intensity and duration of effects due to low systemic drug absorption. Basic and clinical studies have pointed out that the administration of local anesthetics in liposome or cyclodextrin formulations induces slow release of the drugs, prolonging the anesthetic action and decreasing cardiac and nervous systems toxicity. CONCLUSIONS: Although studies are still in progress, drug-delivery systems are flagging a new direction for the development of safer and more effective local anesthetic formulations.
机译:背景与目的:在过去的四十年中,许多研究人员致力于药物输送系统的开发。自从其在制药工业中的首次应用以来,已经获得了许多成果,尤其是在载体的分子操作及其与封装药物的相互作用中。这些新载体的优点是绕过了封装的药物,限制了其理化特性(例如水或膜的溶解性),从而改善了药效学(增强了治疗效果),药代动力学(控制了组织吸收和分布)和毒性(降低了局部和全身毒性) 。脂质体和环糊精是最重要的载体之一,它们在开发用于局部麻醉药的药物递送系统中显示出相当大的优势。这项研究旨在审查局部麻醉剂与脂质体和环糊精的相互作用,除了这些制剂的治疗适用性外,还对该领域的基础研究和应用研究进行了开发。内容:脂质体具有控制药物向靶组织的输送的能力,可将其作用部位的药物释放分级。另一方面,环糊精由于全身药物吸收低而改变了作用的强度和持续时间。基础和临床研究指出,在脂质体或环糊精制剂中施用局部麻醉药可导致药物缓慢释放,延长麻醉作用并降低心脏和神经系统毒性。结论:尽管研究仍在进行中,但药物输送系统正在为开发更安全,更有效的局部麻醉剂开辟新的方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号